InvestorsHub Logo
Followers 3156
Posts 961086
Boards Moderated 205
Alias Born 09/04/2000

Re: None

Thursday, 03/23/2017 1:17:49 PM

Thursday, March 23, 2017 1:17:49 PM

Post# of 144812
22 MAR 2017/ PharmaCyte Biotech Strengthens Protection of Cancer Therapy with Patent Filing

LAGUNA HILLS, Calif., March 22, 2017 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) to protect
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News